List of Excipients in API calcipotriene 0.005% 60 gram foam
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing calcipotriene 0.005% 60 gram foam
Detailed excipient profiles for calcipotriene 0.005% 60 gram foam
Excipient focus: .ALPHA.-TOCOPHEROL, DL-
calcipotriene 0.005% 60 gram foam drug variants containing .ALPHA.-TOCOPHEROL, DL-
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing .ALPHA.-TOCOPHEROL, DL-
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
calcipotriene 0.005% 60 gram foam drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
calcipotriene 0.005% 60 gram foam drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
calcipotriene 0.005% 60 gram foam drug variants containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
calcipotriene 0.005% 60 gram foam drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
calcipotriene 0.005% 60 gram foam drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
calcipotriene 0.005% 60 gram foam drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
calcipotriene 0.005% 60 gram foam drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
calcipotriene 0.005% 60 gram foam drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
calcipotriene 0.005% 60 gram foam drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
calcipotriene 0.005% 60 gram foam drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Trifluent Pharma LLC | calcipotriene 0.005% 60 gram foam | 73352-886 |
| >Company | >Ingredient | >NDC |
calcipotriene 0.005% 60 gram foam drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
